支气管哮喘的免疫治疗进展

被引:11
作者
徐艳
何成诗
机构
[1] 成都中医药大学临床医学院
关键词
支气管哮喘; 特异性免疫治疗; 非特异性免疫治疗; 综述;
D O I
暂无
中图分类号
R562.25 [];
学科分类号
摘要
<正>支气管哮喘是临床常见病和多发病,且近年来发病率有上升趋势,目前病因还不十分清楚,随着对哮喘气道慢性炎症机制的深入研究,免疫学机制在
引用
收藏
页码:121 / 124
页数:4
相关论文
共 7 条
[1]   支气管哮喘非特异性免疫治疗 [J].
赖克方 .
实用医院临床杂志, 2007, (01) :19-21
[2]   Effects of combined BCG and DHEA treatment in preventing the development of asthma [J].
Cui, Yong ;
Choi, Inseon S. ;
Koh, Young-Ah ;
Lin, Xiang-Hua ;
Cho, Yong-Bum ;
Won, Young-Ho .
IMMUNOLOGICAL INVESTIGATIONS, 2008, 37 (03) :191-202
[3]  
Targeting Airway Inflammation in Asthma[J] . Nicola A. Hanania.Chest . 2008 (4)
[4]  
Sublingual immunotherapy induces IL-10–producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation[J] . Barbara Bohle,Tamar Kinaciyan,Marianne Gerstmayr,Astrid Radakovics,Beatrice Jahn-Schmid,Christof Ebner.The Journal of Allergy and Clinical Immunology . 2007 (3)
[5]   The role of regulatory T lymphocytes in asthma pathogenesis [J].
Robinson, DS .
CURRENT ALLERGY AND ASTHMA REPORTS, 2005, 5 (02) :136-141
[6]  
TNF-α and IL-8 of the patients with allergic asthma[J] . Liu Guanghui,Zhu Rongfei,Li Baozhu.Journal of Huazhong University of Science and Technology[Medical Sciences] . 2005 (3)
[7]  
Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling[J] . Gaoyun Yang,Amy Volk,Ted Petley,Eva Emmell,Jill Giles-Komar,Xiaozhou Shang,Jian Li,Anuk M. Das,Dave Shealy,Don E. Griswold,Li Li.Cytokine . 2004 (6)